Xia Xu Selected Research

Emtricitabine (Emtriva)

1/2019	Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate is Non-inferior to Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-naive Adults With Human Immunodeficiency Virus-1 Infection: Week 48 Results of the DRIVE-AHEAD Trial.
1/2018	Raltegravir 1200 mg Once Daily vs 400 mg Twice Daily, With Emtricitabine and Tenofovir Disoproxil Fumarate, for Previously Untreated HIV-1 Infection: Week 96 Results From ONCEMRK, a Randomized, Double-Blind, Noninferiority Trial.
11/2017	Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xia Xu Research Topics

Disease

122	Neoplasms (Cancer) 05/2024 - 01/2005
46	Breast Neoplasms (Breast Cancer) 01/2024 - 10/2004
29	Carcinogenesis 01/2024 - 10/2007
21	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 11/2009
19	Neoplasm Metastasis (Metastasis) 01/2024 - 05/2010
18	Lung Neoplasms (Lung Cancer) 04/2024 - 04/2008
17	Stomach Neoplasms (Stomach Cancer) 01/2024 - 01/2012
16	Inflammation (Inflammations) 03/2024 - 05/2007
16	Infections 04/2023 - 09/2009
11	COVID-19 03/2024 - 01/2020
10	Chronic Obstructive Pulmonary Disease (COPD) 02/2024 - 05/2007
10	Colorectal Neoplasms (Colorectal Cancer) 06/2021 - 01/2011
9	Endometrial Neoplasms (Endometrial Cancer) 11/2021 - 02/2005
9	Prostatic Neoplasms (Prostate Cancer) 12/2020 - 09/2006
8	Obesity 01/2023 - 12/2012
7	Wounds and Injuries (Trauma) 04/2024 - 09/2013
7	Adenocarcinoma of Lung 11/2023 - 01/2013
7	Male Infertility (Male Sterility) 04/2022 - 01/2018
6	Osteoporosis 03/2024 - 12/2012
6	Hypertension (High Blood Pressure) 08/2023 - 11/2008
6	Hypoxia (Hypoxemia) 08/2023 - 01/2018
6	Type 2 Diabetes Mellitus (MODY) 09/2021 - 12/2006
6	Nasopharyngeal Carcinoma 02/2018 - 02/2014
5	Insulin Resistance 02/2024 - 09/2003
5	Glioblastoma (Glioblastoma Multiforme) 12/2023 - 01/2012
5	Pre-Eclampsia (Preeclampsia) 03/2023 - 06/2012
5	Colonic Neoplasms (Colon Cancer) 07/2021 - 01/2010
5	Gout 09/2020 - 01/2015
4	Emphysema 11/2023 - 01/2020
4	Pancreatic Neoplasms (Pancreatic Cancer) 07/2023 - 08/2009
4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2023 - 08/2010
4	Esophageal Neoplasms (Esophageal Cancer) 01/2023 - 01/2014
4	Body Weight (Weight, Body) 01/2021 - 12/2004
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 06/2002
4	Carcinoma (Carcinomatosis) 06/2017 - 10/2013
3	Hepatitis B 12/2024 - 11/2017
3	Hepatocellular Carcinoma (Hepatoma) 05/2024 - 01/2013
3	Nausea 04/2024 - 01/2014
3	Arthritis (Polyarthritis) 02/2024 - 01/2017
3	Fibrosis (Cirrhosis) 10/2023 - 10/2018
3	Heart Failure 09/2023 - 07/2010
3	Diabetes Mellitus 08/2023 - 07/2010

Drug/Important Bio-Agent (IBA)

59	Estrogens (Estrogen)FDA Link 06/2023 - 10/2004
25	Hormones (Hormone)IBA 01/2022 - 01/2005
23	Proteins (Proteins, Gene)FDA Link 01/2024 - 05/2010
22	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2010
21	Estradiol (Delestrogen)FDA LinkGeneric 01/2023 - 09/2003
12	EnzymesIBA 10/2023 - 09/2003
11	Estrone FDA Link 01/2023 - 04/2012
10	Therapeutic UsesIBA 10/2023 - 01/2014
9	CytokinesIBA 03/2024 - 11/2012
9	BNT162 VaccineIBA 03/2024 - 01/2021
9	MicroRNAs (MicroRNA)IBA 02/2024 - 04/2013
9	VaccinesIBA 09/2023 - 01/2021
9	AndrogensIBA 01/2022 - 04/2011
8	RNA (Ribonucleic Acid)IBA 05/2024 - 11/2017
8	DNA (Deoxyribonucleic Acid)IBA 12/2020 - 05/2009
7	Poly(ADP-ribose) Polymerase InhibitorsIBA 02/2024 - 11/2019
7	Testosterone (Sustanon)FDA Link 02/2022 - 11/2008
6	Messenger RNA (mRNA)IBA 03/2024 - 01/2013
6	olaparibIBA 02/2024 - 11/2019
6	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 09/2003
6	SmokeIBA 02/2024 - 11/2009
6	AntioxidantsIBA 01/2024 - 01/2018
6	LipopolysaccharidesIBA 01/2024 - 11/2009
6	PlatinumIBA 01/2023 - 01/2013
6	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2022 - 11/2014
6	Phosphotransferases (Kinase)IBA 11/2019 - 07/2014
5	oridoninIBA 07/2023 - 01/2012
5	Serine Proteases (Serine Protease)IBA 01/2022 - 01/2020
5	Progesterone FDA LinkGeneric 11/2021 - 09/2015
5	ORALIT (ORS)IBA 11/2019 - 04/2013
4	ChitosanIBA 12/2023 - 06/2021
4	Insulin (Novolin)FDA Link 01/2022 - 09/2003
4	TeaIBA 09/2021 - 01/2010
4	LipidsIBA 01/2021 - 08/2014
4	SteroidsIBA 10/2019 - 11/2008
4	efavirenz (Sustiva)FDA Link 01/2019 - 09/2009
4	Raltegravir Potassium FDA Link 01/2018 - 09/2009
4	Uric Acid (Urate)IBA 01/2018 - 01/2015
4	Transaminases (Aminotransferases)IBA 01/2015 - 01/2011
4	Small Interfering RNA (siRNA)IBA 08/2014 - 11/2009
3	OvalbuminIBA 03/2024 - 09/2023
3	Estrogen ReceptorsIBA 01/2024 - 04/2012
3	Polysaccharides (Glycans)IBA 12/2023 - 01/2021
3	HydrogelsIBA 12/2023 - 04/2023
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2023 - 06/2018
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2023 - 01/2018
3	Long Noncoding RNAIBA 01/2023 - 01/2019

Therapy/Procedure

38	Therapeutics 11/2023 - 09/2009
22	Drug Therapy (Chemotherapy) 02/2024 - 01/2010
7	Chinese Traditional Medicine (Traditional Chinese Medicine) 07/2023 - 08/2015
6	Radiotherapy 01/2023 - 10/2008
4	Analgesia 04/2024 - 01/2022
4	Length of Stay 03/2024 - 01/2021
4	Injections 01/2024 - 01/2012
3	Anesthesia 05/2024 - 01/2022
3	General Anesthesia 04/2024 - 06/2020
3	Aftercare (After-Treatment) 07/2023 - 01/2018
3	Lasers (Laser) 01/2023 - 06/2018